Innovation at periodic intervals to upscale the Bone Mineral Densitometry (BMD) Market
Published On :
The Bone Mineral Densitometry (BMD) Market is stipulated to grow at a remarkable rate In Upcoming Years. Cybersecurity is inevitable for verticals all across in wake of cyber intruders. As such, reliable, secure, and fast wireless and wired connectivity are being called for concerning devices, applications, and users across the entire enterprise.
The global bone mineral densitometry (BMD) market was valued at US$ 310.6 Mn in 2020, and is expected to exhibit a CAGR of around 3.5% over the forecast period (2021 – 2031).
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32513
Rise in prevalence of osteoporosis in the aged population and women aged above 50 has led to a surge in demand for bone mineral densitometry. Rising awareness about osteoporosis and efforts by various foundations are increasing awareness among the women population is leading to increased demand for bone densitometers globally.
Increasing number of spinal and hip fractures requiring bone mineral density scanning to avoid re-fractures is leading to higher installation of bone mineral densitometers in healthcare settings. Osteoporosis remains highly underdiagnosed and undertreated in South East Asia and many European countries.
There has been an increase in healthcare expenditure as well as reimbursements policies among developing nations, which is creating higher demand for bone densitometers. New product launches, acquisitions, and collaborations by key players are also expected to aid market expansion.
Company Profiles:
- GE Healthcare
- Hologic, Inc.
- Beammed, Ltd.
- Swissray International, Inc.
- Osteosys Co. Ltd.
- Diagnostic Medical System SA
- Medonica Co., Ltd.
- OsteometerMeditech
- Hitachi Ltd.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/32513
Key Takeaways from Market Study
- Axial bone densitometers hold over 68% value share, globally, as they are used for the detection of bone density in central sites, including the vertebral column, ribcage, and pelvic region.
- Dual X-ray absorptiometry (DXA) is preferred due to higher number of bone density detections at central skeletal sites as compared to peripheral.
- In terms of end user, hospitals contribute maximum share in the market due to higher footfall of patients as compared to other end-user facilities.
- North America remains dominant in the global market for bone mineral densitometers, and will continue to hold strong revenue share of more than 51% over the forecast period.
“BMD is witnessing growth in developed as well as emerging economies due to high prevalence of osteoporosis and osteoporotic fracture-related cases. Advancements in DXA technologies for higher precision and accuracy will lead a path toward improved diagnostic approaches to understand bone pathologies and preventing recurrent fractures,” says an analyst of Persistence Market Research.
Acquisitions and Collaborations – Strategy by Key Players
Key manufacturers of bone mineral densitometers are collaborating with domestic vendors to expand their channel partnerships and increase their regional and global presence.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32513
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the bone mineral densitometry market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.
The research study is based on the product (axial bone densitometry and peripheral bone densitometry), technology (dual-energy X-ray absorptiometry (DXA), peripheral dual energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), and others), and end user (hospitals, orthopaedic clinics, and diagnostic centers), across seven key regions of the world (North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa).
Related Reports:
Bile Duct Cancer Treatment Market
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
Uma Rajagopal has been managing the posting of content for multiple platforms since 2021, including Global Banking & Finance Review, Asset Digest, Biz Dispatch, Blockchain Tribune, Business Express, Brands Journal, Companies Digest, Economy Standard, Entrepreneur Tribune, Finance Digest, Fintech Herald, Global Islamic Finance Magazine, International Releases, Online World News, Luxury Adviser, Palmbay Herald, Startup Observer, Technology Dispatch, Trading Herald, and Wealth Tribune. Her role ensures that content is published accurately and efficiently across these diverse publications.
-
-
FINANCE4 days ago
NDC Wins According to Ghana King, a Voting-prediction App
-
-
-
FINANCE4 days ago
JUSPAY Establishes European Hub in Dublin, Accelerating Global Expansion
-
-
-
NEWS3 days ago
Ant International sees robust growth across pillar businesses of payments, digitalisation, and inclusive financial services in 2024
-
-
-
BUSINESS1 day ago
Germany’s CompuGroup in talks about potential offer by CVC
-